BRCA2 c.2095del ;(p.Q699Sfs*31)

Variant ID: 13-32910587-AC-A

NM_000059.3(BRCA2):c.2095del;(p.Q699Sfs*31)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations.

Jco Precision Oncology
Mota, Jose Mauricio JM; Barnett, Ethan E; Nauseef, Jones T JT; Nguyen, Bastien B; Stopsack, Konrad H KH; Wibmer, Andreas A; Flynn, Jessica R JR; Heller, Glenn G; Danila, Daniel C DC; Rathkopf, Dana D; Slovin, Susan S; Kantoff, Philip W PW; Scher, Howard I HI; Morris, Michael J MJ; Schultz, Nikolaus N; Solit, David B DB; Abida, Wassim W
Publication Date: 2020

Variant appearance in text: BRCA2: Q699Sfs*31
PubMed Link: 32856010
Variant Present in the following documents:
  • Main text
View BVdb publication page